Unknown OBSERVATIONAL NCT01486082

Antimicrobial Susceptibility for Helicobacter Pylori Eradication

Usefulness of Antimicrobial Susceptibility in the Eradication of Helicobacter Pylori

Sponsor: Hospital Donostia

Conditions Helicobacter Pylori Infection

Interventions OCA 10

Updated 7 times since 2017 Last updated: Dec 11, 2011 Started: Feb 28, 2011 Primary completion: Nov 30, 2011 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01486082, this observational or N/A phase trial focuses on Helicobacter Pylori Infection and remains ongoing. Sponsored by Hospital Donostia, it has been updated 7 times since 2011, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE4

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Donostia

Data source: Hospital Donostia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Donostia / San Sebastian, Spain